disopyramide has been researched along with Syndrome in 10 studies
Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Administration of disopyramide was effective in preventing syncope." | 4.02 | Frequent occurrence of postbreakfast syncope due to carotid sinus syndrome after surgery for hypopharyngeal cancer: A case report. ( Ando, Y; Fujita, N; Hashimoto, K; Obuchi, Y; Ono, Y; Sano, A; Tanaka, Y; Tatsushima, D; Tomifuji, M; Watanabe, S; Yanagawa, R, 2021) |
| "Brugada syndrome is characterized by an ST segment elevation in leads V1-V3 and a high incidence of ventricular fibrillation (VF)." | 2.69 | Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. ( Aihara, N; Antzelevitch, C; Kamakura, S; Kurita, T; Shimizu, W; Sunagawa, K; Suyama, K; Taguchi, A; Takaki, H, 2000) |
| "Disopyramide was given to 5 patients resulting in suppression of the arrhythmia and relief of symptoms." | 1.26 | Atrial bigeminy with block associated with bradycardia and paroxysmal atrial fibrillation -- an important variant of the tachycardia-bradycardia syndrome. ( Camm, AJ; Spurrell, RA; Ward, DE; Washington, HG, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, Y | 1 |
| Hashimoto, K | 1 |
| Sano, A | 1 |
| Fujita, N | 1 |
| Yanagawa, R | 1 |
| Ono, Y | 1 |
| Obuchi, Y | 1 |
| Tatsushima, D | 1 |
| Watanabe, S | 1 |
| Tomifuji, M | 1 |
| Tanaka, Y | 1 |
| Mizobuchi, M | 1 |
| Enjoji, Y | 1 |
| Yamamoto, R | 1 |
| Ono, T | 1 |
| Funatsu, A | 1 |
| Kambayashi, D | 1 |
| Kobayashi, T | 1 |
| Nakamura, S | 1 |
| Takagi, M | 1 |
| Aihara, N | 2 |
| Kuribayashi, S | 1 |
| Taguchi, A | 2 |
| Kurita, T | 2 |
| Suyama, K | 2 |
| Kamakura, S | 2 |
| Takamiya, M | 1 |
| McPate, MJ | 1 |
| Duncan, RS | 1 |
| Witchel, HJ | 1 |
| Hancox, JC | 1 |
| Dumaine, R | 1 |
| Antzelevitch, C | 2 |
| Miyazaki, T | 1 |
| Mitamura, H | 1 |
| Miyoshi, S | 1 |
| Soejima, K | 1 |
| Aizawa, Y | 2 |
| Ogawa, S | 1 |
| Chinushi, M | 1 |
| Ogawa, Y | 1 |
| Shiba, M | 1 |
| Takahashi, K | 1 |
| Shimizu, W | 1 |
| Takaki, H | 1 |
| Sunagawa, K | 1 |
| Washington, HG | 1 |
| Ward, DE | 1 |
| Camm, AJ | 1 |
| Spurrell, RA | 1 |
| den Dulk, K | 1 |
| Lindemans, FW | 1 |
| Brugada, P | 1 |
| Smeets, JL | 1 |
| Wellens, HJ | 1 |
1 trial available for disopyramide and Syndrome
| Article | Year |
|---|---|
Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Bundle-Branch Block; Disopyramide; Electrocardiography; Flecain | 2000 |
9 other studies available for disopyramide and Syndrome
| Article | Year |
|---|---|
Frequent occurrence of postbreakfast syncope due to carotid sinus syndrome after surgery for hypopharyngeal cancer: A case report.
Topics: Aged; Anastomosis, Surgical; Breakfast; Carotid Sinus; Deglutition; Disopyramide; Electrocardiograph | 2021 |
Nifekalant and disopyramide in a patient with short QT syndrome: evaluation of pharmacological effects and electrophysiological properties.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Body Surface Potential Mapping; Disopyramide; Humans; M | 2008 |
Abnormal response to sodium channel blockers in patients with Brugada syndrome: augmented localised wall motion abnormalities in the right ventricular outflow tract region detected by electron beam computed tomography.
Topics: Adult; Analysis of Variance; Anti-Arrhythmia Agents; Bundle-Branch Block; Case-Control Studies; Diso | 2003 |
Disopyramide is an effective inhibitor of mutant HERG K+ channels involved in variant 1 short QT syndrome.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; CHO Cells; Cricetinae; Cricetulus; Death, Sud | 2006 |
Disopyramide: although potentially life-threatening in the setting of long QT, could it be life-saving in short QT syndrome?
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Disopyramide; Drug Interaction | 2006 |
Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Calcium Channel Blockers; Disopyramide; Electrocardiography; Humans; | 1996 |
Discrepant drug action of disopyramide on ECG abnormalities and induction of ventricular arrhythmias in a patient with Brugada syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disopyramide; Dose-Response Relationship, | 1997 |
Atrial bigeminy with block associated with bradycardia and paroxysmal atrial fibrillation -- an important variant of the tachycardia-bradycardia syndrome.
Topics: Adult; Aged; Atrial Fibrillation; Bradycardia; Cardiac Complexes, Premature; Disopyramide; Electroca | 1979 |
Pacemaker syndrome with AAI rate variable pacing: importance of atrioventricular conduction properties, medication, and pacemaker programmability.
Topics: Aged; Atrioventricular Node; Bradycardia; Disopyramide; Dizziness; Equipment Design; Exercise; Heart | 1988 |